Literature DB >> 9236850

First- and second-generation antisense inhibitors targeted to human c-raf kinase: in vitro and in vivo studies.

B P Monia1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9236850

Source DB:  PubMed          Journal:  Anticancer Drug Des        ISSN： 0266-9536


× No keyword cloud information.
  10 in total

Review 1.  Antisense cancer therapy: the state of the science.

Authors:  D M Kushner; R H Silverman
Journal:  Curr Oncol Rep       Date:  2000-01       Impact factor: 5.075

2.  ERK5 and ERK2 cooperate to regulate NF-kappaB and cell transformation.

Authors:  G Pearson; J M English; M A White; M H Cobb
Journal:  J Biol Chem       Date:  2000-12-15       Impact factor: 5.157

Review 3.  Antisense pharmacodynamics: critical issues in the transport and delivery of antisense oligonucleotides.

Authors:  R L Juliano; S Alahari; H Yoo; R Kole; M Cho
Journal:  Pharm Res       Date:  1999-04       Impact factor: 4.200

Review 4.  Antisense technology: an overview and prospectus.

Authors:  Stanley T Crooke; Brenda F Baker; Rosanne M Crooke; Xue-Hai Liang
Journal:  Nat Rev Drug Discov       Date:  2021-03-24       Impact factor: 84.694

5.  Oncogenic homeodomain transcription factor E2A-Pbx1 activates a novel WNT gene in pre-B acute lymphoblastoid leukemia.

Authors:  J R McWhirter; S T Neuteboom; E V Wancewicz; B P Monia; J R Downing; C Murre
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

6.  A cytosine analog that confers enhanced potency to antisense oligonucleotides.

Authors:  W M Flanagan; J J Wolf; P Olson; D Grant; K Y Lin; R W Wagner; M D Matteucci
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

7.  Dynamic NMR structures of [Rp]- and [Sp]-phosphorothioated DNA-RNA hybrids: is flexibility required for RNase H recognition?

Authors:  Marco Tonelli; Nikolai B Ulyanov; Todd M Billeci; Boleslaw Karwowski; Piotr Guga; Wojciech J Stec; Thomas L James
Journal:  Biophys J       Date:  2003-10       Impact factor: 4.033

8.  New approaches for cancer treatment: antitumor drugs based on gene-targeted nucleic acids.

Authors:  O A Patutina; N L Mironova; V V Vlassov; M A Zenkova
Journal:  Acta Naturae       Date:  2009-07       Impact factor: 1.845

9.  Association of c-Raf expression with survival and its targeting with antisense oligonucleotides in ovarian cancer.

Authors:  F McPhillips; P Mullen; B P Monia; A A Ritchie; F A Dorr; J F Smyth; S P Langdon
Journal:  Br J Cancer       Date:  2001-11-30       Impact factor: 7.640

10.  Cyclin D1 antisense oligonucleotide inhibits cell growth stimulated by epidermal growth factor and induces apoptosis of gastric cancer cells.

Authors:  Y Saikawa; T Kubota; Y Otani; M Kitajima; I M Modlin
Journal:  Jpn J Cancer Res       Date:  2001-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.